Technetium-99m labeled renal function and imaging agents: III. Synthesis of 99mTc-MAG3 and biodistribution of by-products
Tóm tắt
Từ khóa
Tài liệu tham khảo
Bevis, 1983, A new radiopharmaceutical for gamma camera renography, Nucl. Med. Commun., 4, 386, 10.1097/00006231-198304060-00002
Brandau, 1985, Physikalisch-chemische und biologische eigenschaften von Technetium-99m-Amin-Komplexen
Brandau, 1986, Preliminary clinical comparison of 99mTc-mercaptoacetyltriglycine and 131I-orthoido-hippuric acid, Nuclear Medicine A, 97
Bubeck, 1986, Clinical comparison of I-131 o-iodohippurate with Tc-99m-CO2-DADS-A and Tc-99m MAG3 by simultaneous double tracer measurement, Nucl. Compact., 17, 135
Bubeck, 1987, The tubular extraction rate (TER) of Tc-99m MAG3: A new quantitative parameter for renal function, Nucl. Compact., 18, 260
Bubeck, 1988, Technetium-99m labeled renal function and imaging agents. II. Clinical evaluation of 99mTc-MAG3 (99mTc-Mercaptoacetylglycylglycylglycine), Nucl. Med. Biol., 15, 109
Chervu, 1984, Technetium-99m-labeled p-aminohippuric acid analog: a new renal agent: concise communication, J. Nucl. Med., 25, 1111
Davison, 1979, A tetradendate ligand designed specifically to coordinate technetium, J. Nucl. Med., 20, 641
Friedman, 1973, Thiolation reaction and peptide synthesis, 230
Fritzberg, 1981, Chemical and biological studies of Tc-99m N,N⇔-Bis(mercaptoacetamido)-ethylenediamine: A potential replacement for I-131 iodohippurate, J. Nucl. Med., 22, 258
Fritzberg, 1982, Synthesis and biological evaluation of Tc-99m N,N′-Bis(mercaptoacetyl)2,3-diaminopropanoate: A potential replacement for 131I o-iodohippurate, J. Nucl. Med., 23, 592
Fritzberg, 1982, Biodistribution and renal excretion of 99mTc-N,N′-bis-(mercaptoacetamido)ethylenediamine. Effect of renal tubular transport inhibitors, Int. J. Nucl. Med. Biol., 9, 79, 10.1016/0047-0740(82)90081-X
Fritzberg, 1985, Triamide mercaptide (N3S) ligands for Tc-99m as potential Tc-99m renal function agents, J. Nucl. Med., 26, P19
Fritzberg, 1986, Synthesis and biological evaluation of technetium-99m MAG3 as a hippuran replacement, J. Nucl. Med., 27, 111
Jafri, 1987, Tc-99m Mercaptoacetyltriglycine, MAG3: a comparison with I-131 and I-123 orthoiodohippurate, OIH, for routine work, J. Nucl. Med., 28, 647
Jong de, 1987, Results of ERBF and ERPF Measurements in healthy dogs with two new radiopharmaceutical principles, Vol. 56, 49
Kasina, 1986, Tissue distribution of technetium-99m-diamide-dimercaptide complexes and potential use as renal radiopharmaceuticals, J. Med. Chem., 29, 1933, 10.1021/jm00160a023
McAfee, 1985, Technetium-99m DADS complexes as renal function and imaging agents: II. Biological comparison with iodine-131 hippuran, J. Nucl. Med., 26, 375
Müller-Suur, 1987, Renal and extrarenal handling of a new imaging compound (99mTc-MAG3) in the rat, Vol. 56, 44
Schneider, 1984, N,N′-bis(S-Benzoylmercaptoacetamido)ethylenediamine and propylenediamine ligands as renal function imaging agents: I. Alternate synthetic methods, J. Nucl. Med., 25, 233
Taylor, 1986, Comparison of iodine-131 OIH and technetium-99m MAG3 renal imaging in volunteers, J. Nucl. Med., 27, 795
Taylor, 1987, Evaluation of a Tc-99m MAG-3 kit formulation in normal volunteers and patients with renal failure, J. Nucl. Med., 28, 647
Taylor, 1987, Preliminary evaluation of 99mTc-mercaptoacetyltriglycine as a replacement for 131I OIH, Vol. 56, 38
Zum Winkel, 1964, Nierendiagnostik mit Radioisotopen, 12